Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Company Eli Lilly and Company Buenos Aires S.E.

Equities

LLY

ARDEUT111192

Pharmaceuticals

End-of-day quote Buenos Aires S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
18,300 ARS +3.38% Intraday chart for Eli Lilly and Company +2.60% +80.61%
06-01 Eli Lilly and Company Announces Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting CI
05-30 Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs MT

Business Summary

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (19.5%);

- immunology diseases (11.1%);

- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;

- other (3.3%).

Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Number of employees: 43,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Human Pharmaceutical Products
100.0 %
28,541 100.0 % 34,124 100.0 % +19.56%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
63.9 %
18,190 63.7 % 21,791 63.9 % +19.80%
Europe
18.1 %
4,299 15.1 % 6,175 18.1 % +43.62%
Other Foreign Countries
8.6 %
2,852 10.0 % 2,946 8.6 % +3.30%
Japan
4.9 %
1,747 6.1 % 1,673 4.9 % -4.28%
China
4.5 %
1,453 5.1 % 1,540 4.5 % +5.98%

Managers

Managers TitleAgeSince
David Ricks CEO
 Chief Executive Officer 56 31/12/95
Anat Ashkenazi DFI
 Director of Finance/CFO 51 31/12/00
Ruth Gimeno PSD
 President - -
Diogo Rau CTO
 Chief Tech/Sci/R&D Officer - 16/05/21
David Hyman CTO
 Chief Tech/Sci/R&D Officer - 15/10/23
Alonzo Weems CMP
 Compliance Officer - 31/12/96
Daniel Skovronsky CTO
 Chief Tech/Sci/R&D Officer 50 31/12/17
Edgardo Hernandez PRN
 Corporate Officer/Principal - 31/12/04
Ilya Yuffa PRN
 Corporate Officer/Principal 49 -
Ronald DeMattos
- -

Members of the board

Members of the board TitleAgeSince
Gabrielle Greene-Sulzberger BRD
 Director/Board Member 63 24/01/21
Ralph Alvarez BRD
 Director/Board Member 68 31/03/09
Jon Fyrwald BRD
 Director/Board Member 63 31/12/04
Juan Luciano BRD
 Director/Board Member 62 31/01/16
William Kaelin BRD
 Director/Board Member 66 03/06/12
David Ricks CEO
 Chief Executive Officer 56 31/12/95
Jamere Jackson BRD
 Director/Board Member 54 30/09/16
Katherine Baicker BRD
 Director/Board Member 52 11/12/11
Marschall Runge BRD
 Director/Board Member 69 31/08/13
Karen Walker BRD
 Director/Board Member 62 30/11/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 950,770,386 948,828,714 ( 99.80 %) 365,000 ( 0.0384 %) 99.80 %

Shareholders

NameEquities%Valuation
Lilly Endowment, Inc.
10.35 %
98,423,810 10.35 % 76 879 M $
Vanguard Fiduciary Trust Co.
7.651 %
72,745,011 7.651 % 56 821 M $
PNC Investments LLC
5.410 %
51,438,196 5.410 % 40 178 M $
BlackRock Advisors LLC
5.286 %
50,259,761 5.286 % 39 258 M $
STATE STREET CORPORATION
3.603 %
34,258,566 3.603 % 26 759 M $
Fidelity Management & Research Co. LLC
3.583 %
34,063,734 3.583 % 26 607 M $
Capital Research & Management Co. (World Investors)
2.581 %
24,536,055 2.581 % 19 165 M $
PRIMECAP Management Co.
2.235 %
21,254,190 2.235 % 16 602 M $
T. Rowe Price International Ltd.
2.168 %
20,613,061 2.168 % 16 101 M $
JPMorgan Investment Management, Inc.
1.956 %
18,597,930 1.956 % 14 527 M $
NameEquities%Valuation
Caixa DTVM SA
0.001476 %
421,310 0.001476 % 11 M $
Western Asset Management Company DTVM Ltda.
0.000707 %
201,841 0.000707 % 5 M $
Bram Bradesco Asset Management S/A DTVM
0.000172 %
49,010 0.000172 % 1 M $
Safra Asset Management Ltda.
0.000157 %
44,900 0.000157 % 1 M $
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000041 %
11,739 0.000041 % 306 866 $
XP Allocation Asset Management Ltda.
0.000014 %
3,883 0.000014 % 101 504 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000009 %
2,450 0.000009 % 64 045 $

Holdings

NameEquities%Valuation
IMMUNOCORE HOLDINGS PLC
6.25%
 2,548,145 6.25% 147,792,410 $
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
6.83%
 8,084,411 6.83% 50,293,848 $
PROQR THERAPEUTICS N.V.
16.55%
 13,371,562 16.55% 26,208,262 $
FOGHORN THERAPEUTICS INC.
9.40%
 4,000,000 9.40% 20,920,000 $
MICROTECH MEDICAL (HANGZHOU) CO., LTD.
7.60%
 21,776,804 7.60% 11,332,213 $
AC IMMUNE SA
3.64%
 3,615,328 3.64% 8,279,101 $
PRECISION BIOSCIENCES, INC.
1.81%
 125,405 1.81% 1,218,937 $

Company contact information

Eli Lilly & Co.

Lilly Corporate Center

46285, Indianapolis

+317 276 2000

http://www.lilly.com
address Eli Lilly and Company(LLY)

Group companies

NameCategory and Sector
Eli Lilly SA
Logo Eli Lilly SA

Eli Lilly SA

Pharmaceuticals: MajorHealth Technology

Part of Eli Lilly & Co., Eli Lilly SA is a Swiss company that manufactures medicines. The company is based in Vernier, Switzerland.

Pharmaceuticals: Major
Kinsale Financial Services
ELI Lilly & Company (India) Pvt Ltd.
Logo ELI Lilly & Company (India) Pvt Ltd.

ELI Lilly & Company (India) Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

ELI Lilly & Company (India) Pvt Ltd. manufactures and markets pharmaceutical products. The firm's products treat diabetes, gastric cancer, lung cancer, osteoporosis, rheumatoid arthritis, men's health and growth-hormone deficiency. The company was founded in 1993 and is headquartered in Gurgaon, India.

Pharmaceuticals: Major
Lilly Ventures Fund I LLC
Logo Lilly Ventures Fund I LLC

Lilly Ventures Fund I LLC

Investment ManagersFinance

Lilly Ventures Fund I LLC seeks investment opportunities located in the North American and European regions. The fund targets companies operating in the fields of biotechnology, medical technology and healthcare IT. It provides financing for early stage capital requirements.

Investment Managers
Eli Lilly Export SA (Switzerland)
Logo Eli Lilly Export SA (Switzerland)

Eli Lilly Export SA (Switzerland)

Medical DistributorsDistribution Services

Part of Eli Lilly & Co., Eli Lilly Export SA is a pharmaceutical company based in Vernier, Switzerland. The Swiss company combines care with research to develop innovative solutions for a better life worldwide.

Medical Distributors
Eli Lilly Group Pension Trustees Ltd.
Logo Eli Lilly Group Pension Trustees Ltd.

Eli Lilly Group Pension Trustees Ltd.

Financial ConglomeratesFinance

Part of Eli Lilly & Co., Eli Lilly Group Pension Trustees Ltd. operates as a British dormant company. The company is based in Basingstroke, UK.

Financial Conglomerates
Eli Lilly (Suisse) SA
Eli Lilly Vostok SA
Eli Lilly Services India Pvt Ltd.
Logo Eli Lilly Services India Pvt Ltd.

Eli Lilly Services India Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Eli Lilly & Co., Eli Lilly Services India Pvt Ltd. is an Indian company that discovers, develops, manufactures and sells pharmaceutical products. The company is based in Bangalore, India and was founded in 2015.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
820.3 USD
Average target price
852.5 USD
Spread / Average Target
+3.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Company Eli Lilly and Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW